Logo image of CGNT

COGNYTE SOFTWARE LTD (CGNT) Stock Fundamental Analysis

NASDAQ:CGNT - Nasdaq - IL0011691438 - Common Stock - Currency: USD

10.68  -0.01 (-0.09%)

After market: 10.68 0 (0%)

Fundamental Rating

4

Taking everything into account, CGNT scores 4 out of 10 in our fundamental rating. CGNT was compared to 283 industry peers in the Software industry. CGNT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CGNT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CGNT was profitable.
In the past year CGNT had a positive cash flow from operations.
In the past 5 years CGNT reported 4 times negative net income.
Of the past 5 years CGNT 4 years had a positive operating cash flow.
CGNT Yearly Net Income VS EBIT VS OCF VS FCFCGNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -2.42%, CGNT perfoms like the industry average, outperforming 58.30% of the companies in the same industry.
The Return On Equity of CGNT (-6.08%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.42%
ROE -6.08%
ROIC N/A
ROA(3y)-10.49%
ROA(5y)-6.29%
ROE(3y)-24.24%
ROE(5y)-14.49%
ROIC(3y)N/A
ROIC(5y)N/A
CGNT Yearly ROA, ROE, ROICCGNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

The Gross Margin of CGNT (70.42%) is comparable to the rest of the industry.
CGNT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CGNT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y1.89%
CGNT Yearly Profit, Operating, Gross MarginsCGNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

CGNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CGNT has more shares outstanding
The number of shares outstanding for CGNT has been increased compared to 5 years ago.
CGNT has a worse debt/assets ratio than last year.
CGNT Yearly Shares OutstandingCGNT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CGNT Yearly Total Debt VS Total AssetsCGNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

CGNT has an Altman-Z score of 1.93. This is not the best score and indicates that CGNT is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.93, CGNT perfoms like the industry average, outperforming 48.76% of the companies in the same industry.
CGNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.93
ROIC/WACCN/A
WACC9.14%
CGNT Yearly LT Debt VS Equity VS FCFCGNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.30 indicates that CGNT should not have too much problems paying its short term obligations.
The Current ratio of CGNT (1.30) is comparable to the rest of the industry.
A Quick Ratio of 1.22 indicates that CGNT should not have too much problems paying its short term obligations.
CGNT's Quick ratio of 1.22 is on the low side compared to the rest of the industry. CGNT is outperformed by 61.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.22
CGNT Yearly Current Assets VS Current LiabilitesCGNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

CGNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 128.57%, which is quite impressive.
CGNT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -56.72% yearly.
Looking at the last year, CGNT shows a quite strong growth in Revenue. The Revenue has grown by 11.85% in the last year.
Measured over the past years, CGNT shows a decrease in Revenue. The Revenue has been decreasing by -5.17% on average per year.
EPS 1Y (TTM)128.57%
EPS 3Y-56.72%
EPS 5YN/A
EPS Q2Q%113.04%
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-9.56%
Revenue growth 5Y-5.17%
Sales Q2Q%12.92%

3.2 Future

Based on estimates for the next years, CGNT will show a very strong growth in Earnings Per Share. The EPS will grow by 81.60% on average per year.
The Revenue is expected to grow by 6.46% on average over the next years.
EPS Next Y171.15%
EPS Next 2Y81.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.08%
Revenue Next 2Y10.85%
Revenue Next 3Y6.46%
Revenue Next 5Y6.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CGNT Yearly Revenue VS EstimatesCGNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100M 200M 300M 400M
CGNT Yearly EPS VS EstimatesCGNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 178.00, the valuation of CGNT can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CGNT.
CGNT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.82.
With a Price/Forward Earnings ratio of 65.65, CGNT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as CGNT.
The average S&P500 Price/Forward Earnings ratio is at 21.76. CGNT is valued rather expensively when compared to this.
Industry RankSector Rank
PE 178
Fwd PE 65.65
CGNT Price Earnings VS Forward Price EarningsCGNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

62.19% of the companies in the same industry are more expensive than CGNT, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CGNT indicates a somewhat cheap valuation: CGNT is cheaper than 77.39% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.88
EV/EBITDA 74.83
CGNT Per share dataCGNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

CGNT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CGNT's earnings are expected to grow with 81.60% in the coming years.
PEG (NY)1.04
PEG (5Y)N/A
EPS Next 2Y81.6%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CGNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COGNYTE SOFTWARE LTD

NASDAQ:CGNT (5/23/2025, 4:30:00 PM)

After market: 10.68 0 (0%)

10.68

-0.01 (-0.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-02 2025-04-02/bmo
Earnings (Next)06-16 2025-06-16/bmo
Inst Owners78.25%
Inst Owner Change0.84%
Ins Owners2.15%
Ins Owner Change0%
Market Cap768.53M
Analysts45.71
Price Target10.2 (-4.49%)
Short Float %0.43%
Short Ratio0.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)175.89%
Min EPS beat(2)157.67%
Max EPS beat(2)194.12%
EPS beat(4)4
Avg EPS beat(4)179.96%
Min EPS beat(4)38.24%
Max EPS beat(4)329.82%
EPS beat(8)7
Avg EPS beat(8)503.28%
EPS beat(12)9
Avg EPS beat(12)270.95%
EPS beat(16)12
Avg EPS beat(16)210.89%
Revenue beat(2)0
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-0.54%
Max Revenue beat(2)-0.53%
Revenue beat(4)0
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-1.16%
Max Revenue beat(4)-0.53%
Revenue beat(8)3
Avg Revenue beat(8)-0.11%
Revenue beat(12)4
Avg Revenue beat(12)-3.63%
Revenue beat(16)5
Avg Revenue beat(16)-3.18%
PT rev (1m)33.33%
PT rev (3m)33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)13.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.82%
Valuation
Industry RankSector Rank
PE 178
Fwd PE 65.65
P/S 2.19
P/FCF 22.88
P/OCF 16.43
P/B 3.88
P/tB 10.67
EV/EBITDA 74.83
EPS(TTM)0.06
EY0.56%
EPS(NY)0.16
Fwd EY1.52%
FCF(TTM)0.47
FCFY4.37%
OCF(TTM)0.65
OCFY6.09%
SpS4.87
BVpS2.75
TBVpS1
PEG (NY)1.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.42%
ROE -6.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.42%
FCFM 9.58%
ROA(3y)-10.49%
ROA(5y)-6.29%
ROE(3y)-24.24%
ROE(5y)-14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y1.89%
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 96.6%
Cap/Sales 3.76%
Interest Coverage N/A
Cash Conversion 533.19%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 1.22
Altman-Z 1.93
F-Score6
WACC9.14%
ROIC/WACCN/A
Cap/Depr(3y)75.65%
Cap/Depr(5y)79.28%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128.57%
EPS 3Y-56.72%
EPS 5YN/A
EPS Q2Q%113.04%
EPS Next Y171.15%
EPS Next 2Y81.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.85%
Revenue growth 3Y-9.56%
Revenue growth 5Y-5.17%
Sales Q2Q%12.92%
Revenue Next Year12.08%
Revenue Next 2Y10.85%
Revenue Next 3Y6.46%
Revenue Next 5Y6.46%
EBIT growth 1Y71.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year281.75%
EBIT Next 3Y75.38%
EBIT Next 5Y60.6%
FCF growth 1Y31.78%
FCF growth 3YN/A
FCF growth 5Y-6.04%
OCF growth 1Y35.36%
OCF growth 3Y161.04%
OCF growth 5Y-6.98%